Brief: Bioarctic Updates Regarding Rumors Of Imminent Approval Of Lecanemab In Great Britain
22/08/2024 07:49
Aug 22 (Reuters) - BioArctic AB BIOAb.ST :
* REGARDING RUMORS OF AN IMMINENT APPROVAL OF LECANEMAB IN
GREAT
BRITAIN
* COMPANY HAS CURRENTLY NOT BEEN INFORMED THAT RELEVANT
AUTHORITIES HAVE MADE A DECISION AND CANNOT THEREFORE COMMENT ON
THESE RUMORS
* COMPANY WILL UPDATE MARKET IF NEW INFORMATION BECOMES
AVAILABLE
Source text for Eikon: ID:nWkr87vbNy
Further company coverage: BIOAb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln